InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-11.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Powell Andrew Kenneth William, Director. Director active across 2 companies, notably Landec CORP \ca\. In total, 8 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €10k. History available since 1 June 2021. The latest transaction was disclosed on 1 March 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Powell Andrew Kenneth William
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
4,660 sharesCommon StockSEC:0001415889-24-015368:0
8,500 shares@ US$1.23100.0% of flowCommon StockSEC:0001209191-24-004385:0
Canonical exit: 30 May 2024 (T+90)
4,507 sharesCommon StockSEC:0001209191-23-034399:0
4,000 shares0Common StockSEC:0001209191-23-004300:0
7,059 shares@ US$9.5028.3% of flowCommon StockSEC:0001628280-22-016491:0
709 shares0Common StockSEC:0001209191-22-034601:0
5,500 shares0Common StockSEC:0001209191-21-067863:0
8,303 shares@ US$11.6455.9% of flowCommon StockSEC:0001593968-21-001521:0
8 of 8 declarations
About Powell Andrew Kenneth William
Andrew Kenneth William Powell is a Director at LANDEC CORP \CA\ and Aclaris Therapeutics, Inc. In this role, he contributes to the governance of the companies and strategic decision-making. Powell brings his expertise to support the missions of these firms.
